Disclosed is bucindolol substantially free of its R-stereoisomer. Alsodisclosed are pharmaceutical compositionsthat include bucindolol substantially free of its R-stereoisomer or apharmaceutically acceptable salt thereof, and a pharmaceuticallyacceptable carrier. Also disclosed are methods of treating a patient thatinvolve administering to the patient a therapeuticallyeffective amount of a composition of the present invention. Formula (I).